Company News

SkinMedica Files Patent and Trade Secret Action

Company seeks damages and an injunction against Histogen

Author Image

By: TOM BRANNA

Editor

Dermatologic product supplier SkinMedica, Inc. has initiated a patent and trade secret action against Histogen, Inc., Histogen Aesthetics, LLC and Dr. Gail Naughton, founder, president and chief executive officer of Histogen and Histogen Aesthetics. According to SkinMedica, Dr. Naughton was a co-founder of Advanced Tissue Sciences or ATS. The company acquired several assets from ATS, including intellectual property encompassing its NouriCel technology. The complaint seeks damages and an inju...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters